Aimee Wilkin to HIV Reverse Transcriptase
This is a "connection" page, showing publications Aimee Wilkin has written about HIV Reverse Transcriptase.
Connection Strength
0.400
-
Wilkin A, Pozniak AL, Morales-Ramirez J, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K. Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial. AIDS Res Hum Retroviruses. 2012 May; 28(5):437-46.
Score: 0.400